As results of initial validation by western blotting in relatively advanced cases and further validation including the less advanced cases by western blotting, the expression levels of the four proteins ApoA-IV, GC, RBP4, and CLEC3B were greater in cancer patients than in controls. Here, APOA4 is linked to cancer.